CDMO Market Insight, Pricing and Benchmarking Reports
NICE INSIGHT REPORT

Gene Therapy:Market Insight, CDMO Pricing and Competitor Benchmarking

Updated Monthly
  • 2025 CDMO pricing data for 61 clinical and commercial gene therapy development and manufacturing RFP service line items

  • Exhaustive directory of capabilities profiles for the top 70 CDMOs specializing in gene therapy

  • Technical focus on AAV and LVV manufacturing for a variety of therapeutic applications

  • Includes Nice Insight's Clinical Trials Landscape tool — an in-depth custom research platform for current and upcoming gene therapy trials, sourced from the FDA Clinical Trials Database

Key market insights for innovators, CDMOs, and investors in the gene therapy industry. Mix and match subscriptions to fit your organization's goals.

Trends & Opinions

Trends & Opinions

Immediate access to Nice Insight's Gene Therapy Trends & Opinions section — our SMEs' analysis of where the market is now and where it's headed.

Clinical Trials Landscape

Clinical Trials Landscape

Access to Nice Insight's Gene Therapy Clinical Trials report, plus access to our multi-modality Clinical Trial Landscape tool — an in-depth, interactive study of current and upcoming gene therapy trials.

CDMO Pricing

CDMO Pricing

Access to Nice Insight's Gene Therapy CDMO Pricing Data from 2022-2025, including price breakdowns for over 60 distinct outsourcing RFP service line items.

CDMO Profiles & Capacity

CDMO Profiles & Capacity

Access to Nice Insight's Gene Therapy CDMO Directory, including capabilities for more than 70 gene therapy outsourcing organizations across North America, Europe, and Asia.

Our Market Insight provides preclinical-through-commercial research, data and analysis from Ph.D. scientists and respected voices in biopharma.

Master the Gene Therapy Market, Preclinical through Commercial:

/hubfs/2024%20Reports/10_Gene/01%20pricing%20data%20icon%2065x65@2x.png

Competitive Benchmarking

/hubfs/2024%20Reports/10_Gene/02%20profiles%20icon%2065x65@2x.png

75+ Gene Therapy CDMO Profiles

/hubfs/2024%20Reports/10_Gene/03%20scientific%20analysis%20icon%2065x65@2x.png

Clinical Trials Analysis

/hubfs/2024%20Reports/10_Gene/04%20benefits%20icon%2065x65@2x.png

Biotech Funding Trends

/hubfs/2024%20Reports/10_Gene/05%20investment%20outlook%20icon%2065x65@2x.png

Market Growth Projections

/hubfs/2024%20Reports/10_Gene/06%20innovations%20icon%2065x65@2x.png

Manufacturing Challenges & Innovations

Over 800 hours of data collection and analysis

from interviews, primary research and progressive study.